[Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000649:Amniocentesis; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D000941:Antigens / Q000008:administration & dosage; D001787:Blood Group Incompatibility / Q000276:immunology; D001805:Blood Transfusion, Intrauterine; D004899:Erythroblastosis, Fetal / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005332:Fetoscopy; D006241:Haptens / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D007231:Infant, Newborn; D008715:Methionine / Q000627:therapeutic use; D049590:Postpartum Period; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000032:analysis
D000888:Antibodies, Anti-Idiotypic; D000941:Antigens; D006241:Haptens; D012204:Rh-Hr Blood-Group System; D000324:Adrenocorticotropic Hormone; D008715:Methionine
Terapija i prevencija hemoliticke bolesti novorodenceta uzokovane Rh-faktorom.